Sotera Health (NASDAQ:SHC) Receives "Overweight" Rating from Piper Sandler

Key Points

• Piper Sandler reiterated an Overweight rating and lowered its price target to $22 (from $24), implying roughly a 39% upside from the prior close.
• Sotera beat Q1 estimates with $0.18 EPS and $280.05M revenue (up 10% YoY) and reaffirmed FY2026 guidance of $0.93–$1.01 EPS and approximately $1.2–$1.3B in revenue.
• Potential headwinds include a high valuation and leverage (P/E ~58.6; debt-to-equity 3.66), and a notable insider sale—GTCR sold 10M shares in March, reducing its stake by about 44%.

Sotera Health (NASDAQ:SHC - Get Free Report)'s stock had its "overweight" rating reiterated by Piper Sandler in a research note issued to investors on Wednesday,Benzinga reports. They presently have a $22.00 target price on the stock, down from their previous target price of $24.00. Piper Sandler's target price points to a potential upside of 38.93% from the stock's previous close.

Other research analysts have also recently issued research reports about the company. Zacks Research cut Sotera Health from a "strong-buy" rating to a "hold" rating in a research note on Friday, January 30th. Barclays decreased their price target on Sotera Health from $20.00 to $18.00 and set an "overweight" rating for the company in a research report on Tuesday, April 14th. Royal Bank Of Canada assumed coverage on Sotera Health in a research report on Thursday, January 8th. They issued an "outperform" rating and a $24.00 price target for the company. Wells Fargo & Company lowered Sotera Health to an "overweight" rating in a research report on Thursday, January 8th. Finally, Wall Street Zen lowered Sotera Health from a "strong-buy" rating to a "buy" rating in a research report on Saturday, April 11th. Seven equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $20.33.

Sotera Health Stock Up 3.3%

NASDAQ SHC traded up $0.51 on Wednesday, reaching $15.84. The company had a trading volume of 1,154,593 shares, compared to its average volume of 2,568,500. The firm has a market capitalization of $4.52 billion, a PE ratio of 58.62 and a beta of 1.82. Sotera Health has a 1 year low of $10.80 and a 1 year high of $19.85. The firm has a 50-day moving average of $15.00 and a 200-day moving average of $16.49. The company has a debt-to-equity ratio of 3.66, a current ratio of 2.46 and a quick ratio of 2.24.

Sotera Health (NASDAQ:SHC - Get Free Report) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.18 earnings per share for the quarter, topping analysts' consensus estimates of $0.17 by $0.01. Sotera Health had a return on equity of 42.38% and a net margin of 6.70%.The firm had revenue of $280.05 million during the quarter, compared to analysts' expectations of $270.78 million. During the same quarter in the prior year, the business earned $0.14 EPS. Sotera Health's quarterly revenue was up 10.0% compared to the same quarter last year. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. On average, equities research analysts anticipate that Sotera Health will post 0.88 EPS for the current fiscal year.

Insider Buying and Selling

In other news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the firm's stock in a transaction dated Friday, March 6th. The stock was sold at an average price of $15.27, for a total transaction of $152,700,000.00. Following the completion of the sale, the director directly owned 12,735,301 shares of the company's stock, valued at $194,468,046.27. This trade represents a 43.98% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 15.36% of the company's stock.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the business. Capricorn Fund Managers Ltd bought a new stake in Sotera Health in the fourth quarter valued at about $7,936,000. Nordea Investment Management AB bought a new position in shares of Sotera Health during the 4th quarter worth approximately $1,908,000. Exchange Traded Concepts LLC bought a new position in shares of Sotera Health during the 4th quarter worth approximately $7,739,000. Hudson Bay Capital Management LP bought a new position in shares of Sotera Health during the 3rd quarter worth approximately $3,932,000. Finally, Retirement Systems of Alabama boosted its stake in shares of Sotera Health by 16.9% during the 4th quarter. Retirement Systems of Alabama now owns 248,899 shares of the company's stock worth $4,391,000 after acquiring an additional 35,974 shares during the period. 91.03% of the stock is owned by institutional investors.

Sotera Health News Summary

Here are the key news stories impacting Sotera Health this week:

• Positive Sentiment: Q1 results beat consensus: Sotera reported $0.18 adjusted EPS and $280.05M revenue (up 10% YoY), topping analyst estimates — the official release highlights revenue growth, margin expansion and a return to GAAP net income. Sotera Health Delivers Strong First-Quarter 2026 Results and Reaffirms 2026 Outlook
• Positive Sentiment: Profitability and cash‑flow metrics improved: Adjusted EBITDA rose ~10.5% and the company moved to positive net income versus a year‑ago loss, supporting margin expansion narratives cited by analysts. Sotera Health Company (SHC) Surpasses Q1 Earnings and Revenue Estimates
• Positive Sentiment: Company reaffirmed FY2026 outlook and issued EPS guidance of $0.93–$1.01 and revenue guidance roughly $1.2B–$1.3B, signaling management confidence in mid‑single‑digit growth and margin improvement for the year. Sotera Health Delivers Strong First-Quarter 2026 Results and Reaffirms 2026 Outlook
• Neutral Sentiment: Planned leadership transition announced: Alton Shader will become CEO on May 26, 2026 while current CEO Michael Petras shifts to Executive Chairman — positioned as a planned succession but investors will watch execution risks. Sotera Health Announces Leadership Transition
• Neutral Sentiment: Earnings call and transcripts convey a confident tone and operational momentum; analysts and transcripts note sustained demand in sterilization and testing services but will watch unit volumes and pricing mix. Sotera Health Company (SHC) Q1 2026 Earnings Call Transcript
• Negative Sentiment: Valuation and leverage remain potential headwinds: SHC trades at a high P/E and the company has elevated debt (high debt-to-equity), which could amplify downside if growth or margins disappoint. No article link provided

About Sotera Health

Sotera Health Inc NASDAQ: SHC is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.